Stevens-Johnson syndrome caused by combined use of lamotrigine and fluoxetine and review of the literature

Stevens-Johnson syndrome (SJS) is a rare, life-threatening acute allergic drug reaction presenting with target lesions and blebs of epidermis. Although a variety of etiologies such as infections and underlying malignancies have been implicated as potential causes of SJS, drugs remain the predominant...

Full description

Saved in:
Bibliographic Details
Published in:Central European journal of medicine Vol. 5; no. 6; pp. 733 - 736
Main Authors: Uluğ, Mehmet, Uluğ, Nuray Can, Celen, Mustafa Kemal, Geyik, Mehmet Faruk, Ayaz, Celal
Format: Journal Article
Language:English
Published: Heidelberg Heidelberg : SP Versita 01-12-2010
SP Versita
Walter de Gruyter GmbH
De Gruyter
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Stevens-Johnson syndrome (SJS) is a rare, life-threatening acute allergic drug reaction presenting with target lesions and blebs of epidermis. Although a variety of etiologies such as infections and underlying malignancies have been implicated as potential causes of SJS, drugs remain the predominant inciting agent. This report presents a SJS case due to combined use of lamotrigine and fluoxetine. A 41-year-old man was admitted to our clinic with fever, skin eruptions (especially on the face and trunk) and lesions around the mouth. The patient's history revealed lamotrigine and fluoxetine use during the previous three weeks for major depression. Dermatological examination revealed a typical clinical picture of SJS; his psychotropic medications were all stopped. While topical and ocular prednisolone (1mg/kg/day) cares were initiated, steroid dosage was reduced within 15 days. The condition of patient rapidly improved through this treatment. Effective management of SJS begins with prompt recognition of the entity, combined with attention to each of the major organs that may be affected, potential comorbidities and withdrawal of all potentially causative drugs. Clinicians should bear in mind the possibility that drugs with potential risk in developing SJS must be used carefully.
Bibliography:http://dx.doi.org/10.2478/s11536-010-0001-1
ISSN:1895-1058
1644-3640
2391-5463
DOI:10.2478/s11536-010-0001-1